Drugs / Dexamethasone
Dexamethasone
Drug Approved in the United States; prescription-onlyFluorinated glucocorticoid corticosteroid·First approved·1958
- Registered trials
- 2117
- Ongoing
- 521/ 25%
- Completed
- 1022
- Indications
- 9
Approved indications
| Indication |
|---|
| Rheumatic diseases |
| Severe allergies |
| Asthma |
| COPD |
| Croup |
| Brain swelling |
| Tuberculosis adjunctive use with antibiotics |
| Adrenocortical insufficiency (with mineralocorticoid) |
| Preterm labor fetal benefit |
Clinical trial landscape
2117 registered studies reference this molecule or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 2 | 680 | 182 | 317 | |
| Phase 3 | 423 | 111 | 212 | |
| Phase 4 | 279 | 53 | 141 | |
| Phase 1 | 244 | 43 | 136 | |
| Not applicable | 199 | 44 | 103 | |
| Phase 1/2 | 193 | 60 | 75 | |
| Phase 2/3 | 51 | 16 | 18 | |
| Early Phase 1 | 25 | 6 | 9 | |
| Unknown | 23 | 6 | 11 | |
| All phases | 2117 | 521 | 1022 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Mechanism of action
Provides anti-inflammatory and immunosuppressive effects.
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.